April 2017
ISSN 2397-8554
EISSN 2397-8562
Antibiotics of the Future
Editorial
Review Articles
Future directions for the discovery of antibiotics from actinomycete bacteria
Emerg Top Life Sci (2017) 1 (1): 1–12.
Drug repurposing for antivirulence therapy against opportunistic bacterial pathogens
Emerg Top Life Sci (2017) 1 (1): 13–22.
Disarming the enemy: targeting bacterial toxins with small molecules
Emerg Top Life Sci (2017) 1 (1): 31–39.
Alternative strategies for the study and treatment of clinical bacterial biofilms
Emerg Top Life Sci (2017) 1 (1): 41–53.
The therapeutic potential of bacteriocins as protein antibiotics
Emerg Top Life Sci (2017) 1 (1): 65–74.
Can't you hear me knocking: contact-dependent competition and cooperation in bacteria
Emerg Top Life Sci (2017) 1 (1): 75–83.
-
Cover Image
Cover Image
Three derivatives of one Streptomyces species showing variations in morphological development and pigment production. In this issue, Rebecca Devine, Matthew Hutchings and Neil Holmes explore how the use of new technologies, including improved culture-dependent and -independent techniques, combined with searching underexplored environments, promises to identify a new generation of antibiotics from actinomycete bacteria such as Streptomyces. See pages 1–12 for further details. Image kindly provided by Paul A. Hoskisson (University of Strathclyde, UK).
